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Background
Allergic sensitisations of the immune system involve the 
formation of specific immunoglobulin E (IgE) antibodies 
after (initial) contact with certain otherwise harmless sub­
stances (allergens). Repeated contact with allergens, how­
ever, sensitises the immune system. On subsequent con­
tact, the immune system recognises these allergens and 
this triggers a reaction by its defence mechanisms. Allergic 
reactions can affect different organs, have different degrees 
of severity and show various symptoms. Although allergic 
sensitisations are measurable by analysing the levels of IgE 
antibodies in the blood, detecting these antibodies does 
not provide a measurement of disease, rather they are mere­
ly associated with an increased risk of allergic diseases [1].
There are four different types of allergic reaction. Type I 
hypersensitivity, also referred to as the immediate type, is 
the most common form and it is mediated by IgE antibod­
ies. Some of the best known manifestations of Type I aller­
gies include hay fever and (allergic) asthma. These condi­
tions are among the most common chronic diseases in 
childhood and adolescence, they place significant burdens 
on health and have strong socioeconomic consequences 
[2, 3]. An important aspect of epidemiological allergy 
research is the extent to which sensitisations persist and 
how they may develop or even decline during the life course. 
In particular, this applies to sensitisations to important 
inhalant allergens that play a significant role in the devel­
opment of hay fever and asthma. Only limited data are 
available that can be used to calculate transition probabil­
ities. However, as part of the KiGGS cohort – the largest 
cohort for children and adolescents in Germany – mea­
surements were taken of important specific IgE antibodies 
that are associated with the most commonly occurring 
allergic diseases. These measurements were made during 
the KiGGS baseline study (2003­2006) and KiGGS Wave 2 
(2014­2017). This data can help answer the important ques­
tion about the extent to which allergic sensitisations per­
sist, arise or even decline over a period of more than ten 
years. This article, therefore, uses the longitudinal data 
from the KiGGS cohort to investigate the transition prob­
abilities of allergic sensitisations during the transition from 
childhood to young adulthood.
Indicator and methodology
The analyses are based on measurements made of specific 
IgE antibodies that react against the allergen mixture SX1, 
a mixture of eight common inhalant allergens (timothy, rye­
grass, birch, mugwort, cat and dog dander, house dust mite 
and the fungus Cladosporium herbarum – Phadia, now 
Thermo Scientific, Freiburg). Measurements were made 
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from 2,041 girls and 2,143 boys who participated in the 
cohort study and who were examined both during the base­
line study (2003­2006) and during KiGGS Wave 2 (2014­
2017). The participants were aged 3 years or older at the 
time of the first measurement. Transition probabilities were 
calculated as the percentage probability of a transition from 
non­sensitisation to sensitisation to the allergen mixture 
SX1 or vice versa during the period beginning with the 
KiGGS baseline study and ending with KiGGS Wave 2. The 
value of  ≥0.35 kU/l was used to set the limit of positive 
sensitisations. A possible bias due to selective re­participa­
tion was partially offset by multivariate weighting [4, 5].
KiGGS Wave 2 
Second follow­up to the German Health 
Interview and Examination Survey for Children 
and Adolescents 
Data owner: Robert Koch Institute 
Aim: Providing reliable information on health 
status, health­related behaviour, living condi­
tions, protective and risk factors, and health 
care among children, adolescents and young 
adults living in Germany, with the possibility 
of trend and longitudinal analyses 
Study design: Combined cross­sectional and 
cohort study 
Cross-sectional study in KiGGS Wave 2
Age range: 0 ­17 years
Population: Children and adolescents with 
permanent residence in Germany
Sampling: Samples from official residency 
registries ­ randomly selected children and  
adolescents from the 167 cities and municipal­
ities covered by the KiGGS baseline study
Sample size: 15,023 participants 
KiGGS cohort study in KiGGS Wave 2
Age range: 10 ­31 years
Sampling: Re­invitation of everyone who took 
part in the KiGGS baseline study and who 
was willing to participate in a follow­up 
Sample size: 10,853 participants  
KiGGS survey waves
▶  KiGGS baseline study (2003­2006),  
examination and interview survey
▶  KiGGS Wave 1 (2009­2012),  
interview survey
▶  KiGGS Wave 2 (2014­2017),  
examination and interview survey
More information is available at 
www.kiggs­studie.de/english
Figure 1: Sensitisation to an allergen mixture of eight common inhalant allergens (SX1 test) over a 10-year period of the life course  
(n=2,041 girls, n=2,143 boys)
Source: KiGGS baseline study (2003­2006), KiGGS Wave 2 (2014­2017)
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Results 
Data from the KiGGS baseline study show that 30% of girls 
aged 3 years or older and 39% of boys from the same age 
group (which is significantly more) were found to be sen­
sitive to at least one of eight major inhalant allergens; in 
other words, their SX1 test proved positive. Most of these 
children also continued to have positive SX1 sensitisation 
a good ten years later (Figure 1). Only a small proportion 
of girls (11%) and boys (6%) who had shown sensitisation 
during the baseline study no longer did so during Wave 2.
Among the girls and boys who showed no SX1 sensitisa­
tion at the time of the KiGGS baseline study, the probabil­
ity of becoming sensitised was 21% and 29% respectively 
(a statistically significant difference). This also means that 
79% of girls and 71% of boys remained SX1­negative after 
a good ten years.
Discussion
This study identified clear positive transition probabilities 
for sensitisation to a mix of eight major inhalant allergens 
(SX1 test) for the 10­year follow­up among both genders. 
As such, a far greater level of SX1 sensitisation developed 
over the life course than receded. Overall, this development, 
which was more pronounced among boys than girls, reflects 
the typical differences in gender and age in the incidence 
of IgE­mediated allergic diseases. The results underscore 
the need to further study the factors linked to immune sys­
tem dysregulation, especially among children with a genet­
ic predisposition to allergies. This would enable relevant 
preventive and therapeutic measures to be developed.
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